@270-days: CR = 58% ... TR = 85%What the 2nd dose given @180-days then gives @270-days ...
This pool of patient already excludes 10 patients (the 10 in red that never made it to 180-days). Always with the aim of better assessing what our optimized group could deliver in terms of efficacy.
26 evaluable patients @270-days
4 out of 26 = 15% NR @270-days
15 out of 26 = 58% CR @270-days
7 out of 26 = 27% IR @270-days
22 out of 26 = 85% TR @270-days